-
1
-
-
1842610127
-
Musculoskeletal pain in Europe: Its impact and a comparison of population and medical perceptions of treatment in eight European countries
-
DOI 10.1136/ard.2003.010223
-
Woolf AD, Zeidler H, Haglund U, et al. Musculoskeletal pain in Europe: its impact and a comparison of population and medical perceptions of treatment in eight European countries. Ann Rheum Dis 2004;63:342-7. (Pubitemid 38453297)
-
(2004)
Annals of the Rheumatic Diseases
, vol.63
, Issue.4
, pp. 342-347
-
-
Woolf, A.D.1
Zeidler, H.2
Haglund, U.3
Carr, A.J.4
Chaussade, S.5
Cucinotta, D.6
Veale, D.J.7
Martin-Mola, E.8
-
2
-
-
43649085186
-
Comparison of sleep variables between chronic widespread musculoskeletal pain, insomnia, periodic leg movements syndrome and control subjects in a clinical sleep medicine practice
-
DOI 10.1016/j.sleep.2007.07.007, PII S1389945707002638
-
Okura K, Lavigne GJ, Huynh N, et al. Comparison of sleep variables between chronic widespread musculoskeletal pain, insomnia, periodic leg movements syndrome and control subjects in a clinical sleep medicine practice. Sleep Med 2008;9:352-61. (Pubitemid 351681421)
-
(2008)
Sleep Medicine
, vol.9
, Issue.4
, pp. 352-361
-
-
Okura, K.1
Lavigne, G.J.2
Huynh, N.3
Manzini, C.4
Fillipini, D.5
Montplaisir, J.Y.6
-
3
-
-
33748105797
-
Sleep deprivation and pain perception
-
DOI 10.1016/j.smrv.2005.08.001, PII S1087079205000754
-
Lautenbacher S, Kundermann B, Krieg JC. Sleep deprivation and pain perception. Sleep Med Rev 2006;10:357-69. (Pubitemid 44307712)
-
(2006)
Sleep Medicine Reviews
, vol.10
, Issue.5
, pp. 357-369
-
-
Lautenbacher, S.1
Kundermann, B.2
Krieg, J.-C.3
-
4
-
-
9244236543
-
Sleep deprivation affects thermal pain thresholds but not somatosensory thresholds in healthy volunteers
-
DOI 10.1097/01.psy.0000145912.24553.c0
-
Kundermann B, Spernal J, Huber MT, et al. Sleep deprivation affects thermal pain thresholds but not somatosensory thresholds in healthy volunteers. Psychosom Med 2004;66:932-7. (Pubitemid 39552878)
-
(2004)
Psychosomatic Medicine
, vol.66
, Issue.6
, pp. 932-937
-
-
Kundermann, B.1
Spernal, J.2
Huber, M.T.3
Krieg, J.-C.4
Lautenbacher, S.5
-
5
-
-
33646923473
-
Sleep loss and REM sleep loss are hyperalgesic
-
Roehrs T, Hyde M, Blaisdell B, et al. Sleep loss and REM sleep loss are hyperalgesic. Sleep 2006;29:145-51. (Pubitemid 44019967)
-
(2006)
Sleep
, vol.29
, Issue.2
, pp. 145-151
-
-
Roehrs, T.1
Hyde, M.2
Blaisdell, B.3
Greenwald, M.4
Roth, T.5
-
6
-
-
73649086947
-
Rheumatic manifestations of sleep disorders
-
Moldofsky H. Rheumatic manifestations of sleep disorders. Curr Opin Rheumatol 2010;22:59-63.
-
(2010)
Curr Opin Rheumatol
, vol.22
, pp. 59-63
-
-
Moldofsky, H.1
-
7
-
-
0025266660
-
The American College of Rheumatology 1990. Criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee
-
Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fi bromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72. (Pubitemid 20098653)
-
(1990)
Arthritis and Rheumatism
, vol.33
, Issue.2
, pp. 160-172
-
-
Wolfe, F.1
Smythe, H.A.2
Yunus, M.B.3
Bennett, R.M.4
Bombardier, C.5
Goldenberg, D.L.6
Tugwell, P.7
Campbell, S.M.8
Abeles, M.9
Clark, P.10
Fam, A.G.11
Farber, S.J.12
Fiechtner, J.J.13
Franklin, C.M.14
Gatter, R.A.15
Hamaty, D.16
Lessard, J.17
Lichtbroun, A.S.18
Masi, A.T.19
-
8
-
-
38049152731
-
Employees with fi bromyalgia: Medical comorbidity, healthcare costs, and work loss
-
White LA, Birnbaum HG, Kaltenboeck A, et al. Employees with fi bromyalgia: medical comorbidity, healthcare costs, and work loss. J Occup Environ Med 2008;50:13-24.
-
(2008)
J Occup Environ Med
, vol.50
, pp. 13-24
-
-
White, L.A.1
Birnbaum, H.G.2
Kaltenboeck, A.3
-
9
-
-
77953120247
-
Prevalence of fi bromyalgia: A survey in fi ve European countries
-
Branco JC, Bannwarth B, Failde I, et al. Prevalence of fi bromyalgia: a survey in fi ve European countries. Semin Arthritis Rheum 2010;39:448-53.
-
(2010)
Semin Arthritis Rheum
, vol.39
, pp. 448-453
-
-
Branco, J.C.1
Bannwarth, B.2
Failde, I.3
-
10
-
-
70450177636
-
Fibromyalgia syndrome module at OMERACT 9: Domain construct
-
OMERACT Fibromyalgia Working Group
-
Mease P, Arnold LM, Choy EH, et al.; OMERACT Fibromyalgia Working Group. Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol 2009;36:2318-29.
-
(2009)
J Rheumatol
, vol.36
, pp. 2318-2329
-
-
Mease, P.1
Arnold, L.M.2
Choy, E.H.3
-
11
-
-
67651202661
-
The significance of dysfunctions of the sleeping/waking brain to the pathogenesis and treatment of fi bromyalgia syndrome
-
Moldofsky H. The significance of dysfunctions of the sleeping/waking brain to the pathogenesis and treatment of fi bromyalgia syndrome. Rheum Dis Clin North Am 2009;35:275-83.
-
(2009)
Rheum Dis Clin North Am
, vol.35
, pp. 275-283
-
-
Moldofsky, H.1
-
12
-
-
0016594402
-
Musculosketal symptoms and non-REM sleep disturbance in patients with "fi brositis syndrome" and healthy subjects
-
Moldofsky H, Scarisbrick P, England R, et al. Musculosketal symptoms and non-REM sleep disturbance in patients with "fi brositis syndrome" and healthy subjects. Psychosom Med 1975;37:341-51.
-
(1975)
Psychosom Med
, vol.37
, pp. 341-351
-
-
Moldofsky, H.1
Scarisbrick, P.2
England, R.3
-
13
-
-
56649086860
-
Restorative sleep predicts the resolution of chronic widespread pain: Results from the EPIFUND study
-
Davies KA, Macfarlane GJ, Nicholl BI, et al. Restorative sleep predicts the resolution of chronic widespread pain: results from the EPIFUND study. Rheumatology (Oxford) 2008;47:1809-13.
-
(2008)
Rheumatology (Oxford)
, vol.47
, pp. 1809-1813
-
-
Davies, K.A.1
Macfarlane, G.J.2
Nicholl, B.I.3
-
14
-
-
33845479670
-
Gamma-Hydroxybutyrate/sodium oxybate: Neurobiology, and impact on sleep and wakefulness
-
DOI 10.2165/00023210-200620120-00004
-
Pardi D, Black J. Gamma-hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness. CNS Drugs 2006;20:993-1018. (Pubitemid 44912708)
-
(2006)
CNS Drugs
, vol.20
, Issue.12
, pp. 993-1018
-
-
Pardi, D.1
Black, J.2
-
15
-
-
0031752568
-
Effect of gamma-hydroxybutyrate on pain, fatigue, and the alpha sleep anomaly in patients with fibromyalgia. Preliminary report
-
Scharf MB, Hauck M, Stover R, et al. Effect of gamma-hydroxybutyrate on pain, fatigue, and the alpha sleep anomaly in patients with fi bromyalgia. Preliminary report. J Rheumatol 1998;25:1986-90. (Pubitemid 28459315)
-
(1998)
Journal of Rheumatology
, vol.25
, Issue.10
, pp. 1986-1990
-
-
Scharf, M.B.1
Hauck, M.2
Stover, R.3
Mcdannold, M.4
Berkowitz, D.5
-
16
-
-
0038752729
-
The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia
-
Scharf MB, Baumann M, Berkowitz DV. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fi bromyalgia. J Rheumatol 2003;30:1070-4. (Pubitemid 36529633)
-
(2003)
Journal of Rheumatology
, vol.30
, Issue.5
, pp. 1070-1074
-
-
Scharf, M.B.1
Baumann, M.2
Berkowitz, D.V.3
-
17
-
-
58249095947
-
Sodium oxybate relieves pain and improves function in fi bromyalgia syndrome: A randomized, double-blind, placebo-controlled, multicenter clinical trial
-
Oxybate SXB-26 Fibromyalgia Syndrome Study Group
-
Russell IJ, Perkins AT, Michalek JE; Oxybate SXB-26 Fibromyalgia Syndrome Study Group. Sodium oxybate relieves pain and improves function in fi bromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial. Arthritis Rheum 2009;60:299-309.
-
(2009)
Arthritis Rheum
, vol.60
, pp. 299-309
-
-
Russell, I.J.1
Perkins, A.T.2
Michalek, J.E.3
-
18
-
-
77957870727
-
Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fi bromyalgia syndrome: A double-blind, randomized, placebo-controlled study
-
Moldofsky H, Inhaber NH, Guinta DR, et al. Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fi bromyalgia syndrome: a double-blind, randomized, placebo-controlled study. J Rheumatol 2010;37:2156-66.
-
(2010)
J Rheumatol
, vol.37
, pp. 2156-2166
-
-
Moldofsky, H.1
Inhaber, N.H.2
Guinta, D.R.3
-
19
-
-
79954596913
-
Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fi bromyalgia: Results from a 14-week, randomized, double-blind, placebo-controlled study
-
Sodium Oxybate 06-008 FM Study Group
-
Russell IJ, Holman AJ, Swick TJ, et al.; Sodium Oxybate 06-008 FM Study Group. Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fi bromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study. Pain 2011;152:1007-17.
-
(2011)
Pain
, vol.152
, pp. 1007-1017
-
-
Russell, I.J.1
Holman, A.J.2
Swick, T.J.3
-
20
-
-
0033527361
-
Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome
-
Netzer NC, Stoohs RA, Netzer CM, et al. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999;131:485-91. (Pubitemid 29482391)
-
(1999)
Annals of Internal Medicine
, vol.131
, Issue.7
, pp. 485-491
-
-
Netzer, N.C.1
Stoohs, R.A.2
Netzer, C.M.3
Clark, K.4
Strohl, K.P.5
-
22
-
-
0026165648
-
The fibromyalgia impact questionnaire: Development and validation
-
Burckhardt CS, Clark SR, Bennett RM. The fi bromyalgia impact questionnaire: development and validation. J Rheumatol 1991;18:728-33.
-
(1991)
J Rheumatol
, vol.18
, pp. 728-733
-
-
Burckhardt, C.S.1
Clark, S.R.2
Bennett, R.M.3
-
23
-
-
0023851627
-
A scale for the estimation of sleep problems in clinical research
-
DOI 10.1016/0895-4356(88)90138-2
-
Jenkins CD, Stanton BA, Niemcryk SJ, et al. A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol 1988;41:313-21. (Pubitemid 18089231)
-
(1988)
Journal of Clinical Epidemiology
, vol.41
, Issue.4
, pp. 313-321
-
-
Jenkins, C.D.1
Stanton, B.-A.2
Niemcryk, S.J.3
Rose, R.M.4
-
24
-
-
79952646210
-
Assessing sleep in fi bromyalgia: Investigation of an alternative scoring method for the Jenkins Sleep Scale based on data from randomized controlled studies
-
Crawford BK, Piault EC, Lai C, et al. Assessing sleep in fi bromyalgia: investigation of an alternative scoring method for the Jenkins Sleep Scale based on data from randomized controlled studies. Clin Exp Rheumatol 2010;28(6 Suppl 63):S100-9.
-
(2010)
Clin Exp Rheumatol
, vol.28
, Issue.6 SUPPL. 63
-
-
Crawford, B.K.1
Piault, E.C.2
Lai, C.3
-
25
-
-
0026877917
-
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection
-
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
-
(1992)
Med Care
, vol.30
, pp. 473-483
-
-
Ware Jr., J.E.1
Sherbourne, C.D.2
-
26
-
-
0025688231
-
EuroQol - A new facility for the measurement of health-related quality of life
-
The EuroQol group
-
The EuroQol group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
-
(1990)
Health Policy
, vol.16
, pp. 199-208
-
-
-
27
-
-
0030834463
-
An instrument to measure functional status outcomes for disorders of excessive sleepiness
-
Weaver TE, Laizner AM, Evans LK, et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep 1997;20:835-43. (Pubitemid 27524711)
-
(1997)
Sleep
, vol.20
, Issue.10
, pp. 835-843
-
-
Weaver, T.E.1
Laizner, A.M.2
Evans, L.K.3
Maislin, G.4
Chugh, D.K.5
Lyon, K.6
Smith, P.L.7
Schwartz, A.R.8
Redline, S.9
Pack, A.I.10
Dinges, D.F.11
-
28
-
-
0031058551
-
A standardized Manual Tender Point Survey. I. Development and determination of a threshold point for the identification of positive tender points in fibromyalgia syndrome
-
Okifuji A, Turk DC, Sinclair JD, et al. A standardized manual tender point survey. I. Development and determination of a threshold point for the identification of positive tender points in fi bromyalgia syndrome. J Rheumatol 1997;24:377-83. (Pubitemid 27104106)
-
(1997)
Journal of Rheumatology
, vol.24
, Issue.2
, pp. 377-383
-
-
Okifuji, A.1
Turk, D.C.2
Sinclair, J.D.3
Starz, T.W.4
Marcus, D.A.5
-
29
-
-
0008946321
-
ECDEU Assessment Manual for Psychopharmacology
-
revised Rockville, MD: US Department of Health, Education, and Welfare
-
Guy W. ECDEU Assessment Manual for Psychopharmacology (revised). DHEW publication no. (ADM) 76-338. Rockville, MD: US Department of Health, Education, and Welfare 1976.
-
(1976)
DHEW Publication No. (ADM) 76-338
-
-
Guy, W.1
-
30
-
-
64849117499
-
The efficacy and safety of milnacipran for treatment of fi bromyalgia. A randomized, double-blind, placebo-controlled trial
-
Mease PJ, Clauw DJ, Gendreau RM, et al. The efficacy and safety of milnacipran for treatment of fi bromyalgia. a randomized, double-blind, placebo-controlled trial. J Rheumatol 2009;36:398-409.
-
(2009)
J Rheumatol
, vol.36
, pp. 398-409
-
-
Mease, P.J.1
Clauw, D.J.2
Gendreau, R.M.3
-
31
-
-
34247646890
-
The effects of sleep deprivation on pain inhibition and spontaneous pain in women
-
Smith MT, Edwards RR, McCann UD, et al. The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep 2007;30:494-505. (Pubitemid 46668707)
-
(2007)
Sleep
, vol.30
, Issue.4
, pp. 494-505
-
-
Smith, M.T.1
Edwards, R.R.2
McCann, U.D.3
Haythomthwaite, J.A.4
-
32
-
-
14044269308
-
Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition
-
DOI 10.1016/j.pain.2004.12.032
-
Julien N, Goffaux P, Arsenault P, et al. Widespread pain in fi bromyalgia is related to a deficit of endogenous pain inhibition. Pain 2005;114:295-302. (Pubitemid 40279112)
-
(2005)
Pain
, vol.114
, Issue.1-2
, pp. 295-302
-
-
Julien, N.1
Goffaux, P.2
Arsenault, P.3
Marchand, S.4
-
33
-
-
67149107748
-
Minimal clinically important difference in the fi bromyalgia impact questionnaire
-
Bennett RM, Bushmakin AG, Cappelleri JC, et al. Minimal clinically important difference in the fi bromyalgia impact questionnaire. J Rheumatol 2009;36:1304-11.
-
(2009)
J Rheumatol
, vol.36
, pp. 1304-1311
-
-
Bennett, R.M.1
Bushmakin, A.G.2
Cappelleri, J.C.3
-
34
-
-
0032956065
-
Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II
-
DOI 10.2165/00019053-199915020-00003
-
Samsa G, Edelman D, Rothman ML, et al. Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics 1999;15:141-55. (Pubitemid 29093257)
-
(1999)
PharmacoEconomics
, vol.15
, Issue.2
, pp. 141-155
-
-
Samsa, G.1
Edelman, D.2
Rothman, M.L.3
Williams, G.R.4
Lipscomb, J.5
Matchar, D.6
-
35
-
-
51349119038
-
Duloxetine for painful diabetic neuropathy and fi bromyalgia pain: Systematic review of randomised trials
-
Sultan A, Gaskell H, Derry S, et al. Duloxetine for painful diabetic neuropathy and fi bromyalgia pain: systematic review of randomised trials. BMC Neurol 2008;8:29.
-
(2008)
BMC Neurol
, vol.8
, pp. 29
-
-
Sultan, A.1
Gaskell, H.2
Derry, S.3
-
36
-
-
77954160849
-
Pregabalin in fi bromyalgia - Responder analysis from individual patient data
-
Straube S, Derry S, Moore RA, et al. Pregabalin in fi bromyalgia - responder analysis from individual patient data. BMC Musculoskelet Disord 2010;11:150.
-
(2010)
BMC Musculoskelet Disord
, vol.11
, pp. 150
-
-
Straube, S.1
Derry, S.2
Moore, R.A.3
-
37
-
-
57649234533
-
Milnacipran for the treatment of fi bromyalgia in adults: A 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial
-
Clauw DJ, Mease P, Palmer RH, et al. Milnacipran for the treatment of fi bromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 2008;30:1988-2004.
-
(2008)
Clin Ther
, vol.30
, pp. 1988-2004
-
-
Clauw, D.J.1
Mease, P.2
Palmer, R.H.3
-
38
-
-
49649095341
-
A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fi bromyalgia
-
Arnold LM, Russell IJ, Diri EW, et al. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fi bromyalgia. J Pain 2008;9:792-805.
-
(2008)
J Pain
, vol.9
, pp. 792-805
-
-
Arnold, L.M.1
Russell, I.J.2
Diri, E.W.3
-
39
-
-
4444381930
-
A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder
-
DOI 10.1002/art.20485
-
Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fi bromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004;50:2974-84. (Pubitemid 39209537)
-
(2004)
Arthritis and Rheumatism
, vol.50
, Issue.9
, pp. 2974-2984
-
-
Arnold, L.M.1
Lu, Y.2
Crofford, L.J.3
Wohlreich, M.4
Detke, M.J.5
Iyengar, S.6
Goldstein, D.J.7
-
40
-
-
28644442626
-
A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder
-
DOI 10.1016/j.pain.2005.06.031, PII S0304395905004628
-
Arnold LM, Rosen A, Pritchett YL, et al. A randomized, double-blind, placebocontrolled trial of duloxetine in the treatment of women with fi bromyalgia with or without major depressive disorder. Pain 2005;119:5-15. (Pubitemid 41752960)
-
(2005)
Pain
, vol.119
, Issue.1-3
, pp. 5-15
-
-
Arnold, L.M.1
Rosen, A.2
Pritchett, Y.L.3
D'Souza, D.N.4
Goldstein, D.J.5
Iyengar, S.6
Wernicke, J.F.7
-
41
-
-
40649095921
-
A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia
-
Mease PJ, Russell IJ, Arnold LM, et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fi bromyalgia. J Rheumatol 2008;35:502-14. (Pubitemid 351374429)
-
(2008)
Journal of Rheumatology
, vol.35
, Issue.3
, pp. 502-514
-
-
Mease, P.J.1
Russell, I.J.2
Arnold, L.M.3
Florian, H.4
Young Jr., J.P.5
Martin, S.A.6
Sharma, U.7
-
42
-
-
20244389715
-
Pregabalin for the treatment of Fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial
-
DOI 10.1002/art.20983
-
Crofford LJ, Rowbotham MC, Mease PJ, et al.; Pregabalin 1008-105 Study Group. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:1264-73. (Pubitemid 40530135)
-
(2005)
Arthritis and Rheumatism
, vol.52
, Issue.4
, pp. 1264-1273
-
-
Crofford, L.J.1
Rowbotham, M.C.2
Mease, P.J.3
Russell, I.J.4
Dworkin, R.H.5
Corbin, A.E.6
Young Jr., J.P.7
LaMoreaux, L.K.8
Martin, S.A.9
Sharma, U.10
-
43
-
-
43749108365
-
What are the key symptoms of fi bromyalgia? Results of a survey of the German Fibromyalgia Association
-
Häuser W, Zimmer C, Felde E, et al. [What are the key symptoms of fi bromyalgia? Results of a survey of the German Fibromyalgia Association]. Schmerz 2008;22:176-83.
-
(2008)
Schmerz
, vol.22
, pp. 176-183
-
-
Häuser, W.1
Zimmer, C.2
Felde, E.3
-
44
-
-
33947366834
-
An internet survey of 2,596 people with fi bromyalgia
-
Bennett RM, Jones J, Turk DC, et al. An internet survey of 2,596 people with fi bromyalgia. BMC Musculoskelet Disord 2007;8:27.
-
(2007)
BMC Musculoskelet Disord
, vol.8
, pp. 27
-
-
Bennett, R.M.1
Jones, J.2
Turk, D.C.3
-
45
-
-
77951735184
-
The American College of Rheumatology preliminary diagnostic criteria for fi bromyalgia and measurement of symptom severity
-
Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fi bromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010;62:600-10.
-
(2010)
Arthritis Care Res (Hoboken)
, vol.62
, pp. 600-610
-
-
Wolfe, F.1
Clauw, D.J.2
Fitzcharles, M.A.3
|